Glimepirid Sandoz

Glimepirid Sandoz is a prescription oral medication that contains the sulfonylurea active ingredient glimepiride. It is supplied as tablets (strength may vary) and is marketed in the European Union. The product belongs to the antidiabetic (oral hypoglycemic) therapeutic class and works by stimulating insulin release from pancreatic beta cells to help control blood glucose levels in people with type 2 diabetes.

Glimepirid Sandoz is indicated for the management of type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient. It is used as part of a comprehensive diabetes treatment plan and may be combined with other antidiabetic agents.

- Adjunct to diet and exercise in adults with type 2 diabetes. - Combination therapy with metformin or other oral hypoglycemics. - May be prescribed when glycemic control is not achieved with lifestyle changes alone. - Used to improve fasting and post‑prandial blood glucose levels. - Considered for patients who require a sulfonylurea class agent.

Glimepirid Sandoz can cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require medical attention.

Common: - Hypoglycemia (low blood sugar) - Headache - Dizziness - Nausea or abdominal discomfort - Weight gain - Skin rash or itching

Serious: - Severe hypoglycemia leading to loss of consciousness - Allergic reactions such as angioedema or Stevens‑Johnson syndrome - Hepatic dysfunction - Hematologic abnormalities (e.g., leukopenia, thrombocytopenia)

Before starting Glimepirid Sandoz, certain health considerations should be reviewed to ensure safe use.

- Assess renal and hepatic function, as impairment may affect drug clearance. - Monitor blood glucose regularly to avoid hypoglycemia. - Use with caution in elderly patients who may be more sensitive to glucose lowering. - Evaluate for a history of cardiovascular disease, as sulfonylureas may have cardiac effects. - Discuss pregnancy or breastfeeding plans with a healthcare professional. - Review any history of allergic reactions to sulfonylureas.

Glimepirid Sandoz may interact with several medications, altering its effectiveness or increasing risk of adverse effects.

Avoid: - Other sulfonylureas or meglitinides, which can increase hypoglycemia risk. - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that may raise glimepiride levels. - High‑dose salicylates, which can potentiate hypoglycemic action.

Use with caution: - Beta‑blockers, which may mask hypoglycemia symptoms. - ACE inhibitors or diuretics, which can affect renal function. - Anticoagulants, as glycemic fluctuations may influence INR. - Alcohol, which can enhance hypoglycemic episodes.